Who is sponsoring NCT03329859?

NCT03329859 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT03329859?

Interventions in NCT03329859: High resolution standardized laparoscopic cholecystectomy.

What condition does NCT03329859 study?

NCT03329859 studies Workflow, Costs, Laparoscopy, Cholecystectomy.

Is NCT03329859 still recruiting?

NCT03329859 is currently completed. Last updated 6 November 2017.

Last reviewed 2017-11-06 · How we verify

NCT03329859

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Microcomplications in Lap. Cholecystectomy: Reducing Intraoperative Interruptions by High Resolution Standardization

Completed NA Last updated 6 November 2017

What this trial tests

NA trial testing High resolution standardized laparoscopic cholecystectomy in Workflow in 39 participants. Completed in 30 November 2016.

Timeline

1 May 2012

Primary endpoint
30 June 2015

30 November 2016

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	health services research
Enrollment	39
Start date	1 May 2012
Primary completion	30 June 2015
Estimated completion	30 November 2016
Sites	1 location across Switzerland

Drugs / interventions tested

High resolution standardized laparoscopic cholecystectomy

Conditions studied

Workflow — all drugs for Workflow →
Costs — all drugs for Costs →
Laparoscopy — all drugs for Laparoscopy →
Cholecystectomy — all drugs for Cholecystectomy →

Sponsor

University Hospital, Basel, Switzerland

Who can join

18 and older, any sex, with Workflow or Costs. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: Investigators aimed to evaluate the impact of a high resolution standardized laparoscopic (HRSL) cholecystectomy protocol on operative time and intraoperative interruptions in a teaching hospital. Background: Interruptions of the surgical workflow or microcomplications (MC) lead to prolonged procedure times and costs and can be indicative for surgical mistakes. Reducing MC can improve operating room efficiency and prevent intraoperative complications. Methods: Audio video records of laparoscopic cholecystectomies were reviewed regarding type, frequency and duration of MC before and after the implementation of a HRSL which included the introduction of a stepwise protocol for the procedure and a teaching video. After consent operating team members were obliged to prepare the operation with these resources.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

High-resolution standardization reduces delay due to workflow disruptions in laparoscopic cholecystectomy.
von Strauss Und Torney M, Aghlmandi S, Zeindler J, Nowakowski D, et al · · 2018 · cited 6× · PMID 29785458 · DOI 10.1007/s00464-018-6224-y

Verify or expand the search:

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03329859 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 6 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03329859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing